NCT00567021已完成不适用
German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 67,130
- 主要终点
- To gain further insight into the efficacy of esomeprazole under ordinary medical care conditions in consideration of diagnosis and type of NSAID therapy (if administered).
研究概览
简要总结
This PMS study had the objective to evaluate under ordinary medical care conditions the efficacy and tolerability of esomeprazole in patients who where treated by general practitioners and internists.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with GERD, or NSAID related ulcers, who need treatment with esomeprazole.
排除标准
- •Limitations; possible risks; warnings; contraindications mentioned in the SPC.
结局指标
主要结局
To gain further insight into the efficacy of esomeprazole under ordinary medical care conditions in consideration of diagnosis and type of NSAID therapy (if administered).
时间窗: By estimating the proportion of treated subjects without any gastrointestinal symptoms at the end of the observational period 2. by assessing the change in intensity of gastrointestinal symptoms.
次要结局
- To get further insight into the details of the use, dosage scheme and duration of treatment with esomeprazole in this population
研究者
相似试验
已完成
不适用
Efficacy and safety of using insulin glargine 300 U/mL in patients on advanced insulin therapy with type 1 or type 2 diabetes failing to achieve their glycemic targets. The Toujeo-Neo trial.ISRCTN93674355Sanofi-Aventis Deutschland GmbH2,500
已完成
不适用
Evaluation of the therapeutic benefit of rPMS applied to the trapezius muscle to treat migraine combined with myofascial paiG43M79Other soft tissue disorders, not elsewhere classifiedMigraineDRKS00019870Klinikum rechts der Isar der TU München37
已完成
1 期
A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 DiabetesDiabetesDiabetes Mellitus, Type 1NCT01114542Novo Nordisk A/S66
已完成
2 期
The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate HypercholesterolemiaHypercholesterolemiaNCT00405067Aegerion Pharmaceuticals, Inc.60
已完成
2 期
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentNon-small Cell Lung CancerNCT00606502Spectrum Pharmaceuticals, Inc201